首页|PLT、MPV、BNP联合检测在肺源性心脏病患者中的应用研究

PLT、MPV、BNP联合检测在肺源性心脏病患者中的应用研究

扫码查看
目的 探讨血小板计数(PLT)、平均血小板体积(MPV)、B型钠尿肽(BNP)联合检测在肺源性心脏病(肺心病)患者中的应用效果。方法 选取2019年3月至2022年4月因呼吸困难在该院呼吸科住院的患者180例,将其分为非肺心病组(95例)和肺心病组(85例)。同时,根据治疗时间将肺心病组进一步分为急性加重期组(85例)和缓解期组(85例)。比较各组PLT、MPV、BNP指标变化情况,并对BNP水平与MPV、PLT水平的相关性进行分析。结果 急性加重期组、缓解期组PLT水平显著低于非肺心病组,而MPV、BNP水平显著高于非肺心病组,差异有统计学意义(P<0。05)。急性加重期组、缓解期组PLT、MPV、BNP水平比较,差异有统计学意义(P<0。05)。肺心病组 BNP[(332。24±37。10)μg/mL]及 MPV[(11。92±1。26)fL]水平明显高于非肺心病组,PLT[(142。25±31。32)×109/L]水平明显低于非肺心病组,差异有统计学意义(P<0。05)。剔除非肺心病组后进行相关性分析,BNP水平与MPV水平呈正相关(r=0。357,P<0。001),BNP水平与PLT水平呈负相关(r=-0。260,P=0。048),PLT水平与MPV水平呈负相关(r=-0。340,P<0。001)。结论 BNP对肺心病的诊断及病情的判断具有重要意义。MPV与PLT、BNP联合检测时,可以成为评估肺心病患者心功能不全和血栓易感的一个重要临床指标。
Application study of combined detection of PLT,MPV and BNP in patients with pulmonary heart disease
Objective To explore the application effect of combined detection of platelet count(PLT),mean platelet volume(MPV)and B-type natriuretic peptide(BNP)in patients with pulmonary heart disease.Methods A toatl of 180 patients hospitalized in the respiratory department of the hospital from March 2019 to April 2022 due to dyspnea were selected and divided into the non-pulmonary heart disease group(95 cases)and the pulmonary heart disease group(85 cases).Meanwhile,the pulmonary heart disease group was further divided into the acute exacerbation group(85 cases)and the remission group(85 cases)based on the treatment time.The changes in PLT,MPV,and BNP indicators among different groups were compared,and the correla-tion between BNP levels and MPV and PLT levels was analyzed.Results The PLT levels in the acute exacer-bation and remission groups were significantly lower than those in the non-pulmonary heart disease group,while the MPV and BNP levels were significantly higher than those in the non-pulmonary heart disease group,with statistically significant differences(P<0.05).There were statistically significant differences in PLT,MPV and BNP levels between the acute exacerbation group and the remission group(P<0.05).The levels of BNP[(332.24±37.10)μg/mL]and MPV[(11.92±1.26)fL]in the pulmonary heart disease group were significantly higher than those in the non-pulmonary heart disease group,while the levels of PLT[(142.25± 31.32)× 109/L]were significantly lower than those in the non-pulmonary heart disease group,and the differ-ences were statistically significant(P<0.05).After excluding the non-pulmonary heart disease group,the cor-relation analysis showed that the BNP levels were positively correlated with the MPV levels(r=0.357,P<0.001),the BNP levels were negatively correlated with the PLT levels(r=-0.260,P=0.048),and the PLT levels were negatively correlated with the MPV levels(r=-0.340,P<0.001).Conclusion BNP is of great significance in the diagnosis of pulmonary heart disease and the assessment of disease status.When combined with PLT and BNP,MPV can become an important clinical indicator for evaluating heart failure and suscepti-bility to thrombosis in patients with pulmonary heart disease.

Pulmonary heart diseaseB-type natriuretic peptidePlatelet

吴颖、高蔚、翁婷

展开 >

徐州医科大学附属宿迁医院/南京鼓楼医院集团宿迁医院呼吸科,江苏宿迁 223800

肺源性心脏病 B型钠尿肽 血小板

2024

现代医药卫生
重庆市卫生信息中心

现代医药卫生

影响因子:0.758
ISSN:1009-5519
年,卷(期):2024.40(8)
  • 18